11327 M. Costa/J. Boldrini: Chemotherapeutic treatments - a study of
the interplay among drug resistance, toxicity and recuperation from
side effects. Bull. Math. Biol. 59 (1997), 205-232.

10355 M. Costa/J. Boldrini: Conflicting objectives in chemotherapy
with drug resistance. Bull. Math. Biol. 59 (1997), 707-724.

21176 John Harrold: Model-based design of cancer chemotherapy treatment
schedules. PhD thesis Univ. Pittsburgh 2005, 197p.

21174 John Harrold/Robert Parker: Clinically relevant cancer chemotherapy
dose scheduling via mixed-integer optimization.
Computers & Chemical Eng. ... (2009), 13p.

21177 Xiao Hu: Optimization of cancer chemotherapy - local delivery
of paclitaxel and pharmacokinetics of suramin.
PhD thesis Ohio State Univ. 2004, 181p.

10358 Denise Kirschner/G. Webb: Understanding drug resistance for
monotherapy treatment of HIV infections.
Bull. Math. Biol. 59 (1997), 763-785.

21399 Wayne Materi/David Wishart: Computational systems biology
in drug discovery and development - methods and applications.
Drug Discovery Today 12/7-8 (2007), 295-303.

21175 Robert Parker: II. Modeling for anti-cancer chemotherapy design.
J. Process Control 17/7 (2007), 576-582.

21186 Andrei Petrovski/John McCall: Computational optimisation of cancer
chemotherapies using genetic algorithms. Internet ca. 2004, 7p.